Biosimilar adoption in RA remains low
Center for Biosimilars: Rheumatologists are comfortable with biosimilars, but still hesitant to prescribe
Sonia Oskouei, PharmD, Vice President of Biosimlars at Cardinal Health, provides perspective on Rheumatology Insights, a Cardinal Health research report showing that although rheumatologists feel comfortable using biosimilars, most are still hesitant to switch patients from branded biologics. Sonia explores some of the reasons why in this Center for Biosimilars article.